Benefits · 7 min read
How brokers can add a GLP-1 program to their benefits lineup
Brokers do not need another one-size-fits-all product pitch. Clients need a disciplined way to compare a separate GLP-1 program with their existing formulary, reimbursement options and administrative capacity.
A useful broker workflow starts with discovery, moves through a consistent comparison and ends with signed responsibilities—not a promise of prescriptions or savings.
Which client questions come first?
Ask whether the current health plan covers weight-loss GLP-1 medicines and for which indications. Request current formulary and utilization documents rather than relying on an employee’s experience or an old renewal summary.
Then discuss the client’s goals. Do they want a defined contribution for active participants, an HRA, a formulary change or a pilot? Which employee classes and states are involved? Who owns implementation, employee communications and invoice review?
KFF’s 2026 survey gives market context: 18% of firms with at least 200 workers covered GLP-1 agonists primarily for weight loss in their largest-enrollment plan. The rate varied by firm size, and some respondents did not know their plan’s position. Verification remains the first deliverable.
How should brokers compare options?
Use one table for every route: eligible population, billing denominator, program fee, medication treatment, employee share, clinical requirements, contracts, reporting and launch responsibilities.
Kindr Benefits models $199 per active enrolled participant per month, with medication separate. A health-plan option uses the plan’s formulary and cost sharing. An HRA reimburses eligible expenses under its written terms. None should be described as a guarantee of clinical eligibility or total-cost savings.
Our comparison hub keeps those line items consistent. The glossary can also help clients distinguish PEPM from active-participant pricing.
How does the Kindr partner model work?
The blueprint models a $20 monthly commission per active participant, paid under signed partner terms. Applying does not approve an agency. Business credentials and relevant states are reviewed, and license verification is a separate step.
A referral code can tag an employer proposal request to a broker. It does not create a payable commission by itself. The signed agreement should define attribution, eligible activity, reversals, payment timing and what happens when participation ends.
Do not show the illustrative portal as proof of earned commissions or client activity. Reconciled records after launch are the appropriate source.
Where does the broker’s role stop?
Brokers can advise on benefits structure and coordinate qualified legal, tax and insurance review. They do not decide who receives a prescription. They should never collect employee medical histories in a CRM or send them to the employer.
Keep client business contacts and employee clinical intake in separate systems. If an employee asks for clinical help, route that person to the clinical workflow rather than answering through the employer pipeline.
What makes a client-ready recommendation?
Disclose compensation and distinguish modeled terms from signed ones. Include alternatives when they fit, not just the vendor offering a commission. Identify remaining legal, tax, clinical and pharmacy checks.
Then stay close to implementation: proposal, contract readiness, employee materials, reporting limits and invoice reconciliation. That is more valuable than a launch announcement with no operating detail.
Visit the GLP-1 benefits for brokers hub for the program model, review the partner terms, and apply as a broker when your agency is ready for review.
This article is educational and is not legal, tax, insurance or medical advice.
Sources
- KFF, 2026 Employer Health Benefits Survey, published October 22, 2026 — www.kff.org/health-costs/2026-employer-health-benefits-survey
- U.S. Department of Labor, Health Benefits Advisor for Employers — webapps.dol.gov/elaws/ebsa/health/employer/1E30.asp
- HHS, Employers and Health Information in the Workplace, content last reviewed November 2, 2020 — www.hhs.gov/hipaa/for-individuals/employers-health-information-workplace/index.html
Menopause weight gain has a cause — and a protocol.
The metabolic slowdown of menopause is driven by estrogen-related insulin resistance, cortisol, and muscle loss. The kindr Metabolic Reset addresses all three.
Medically reviewed by Kindr Health Clinical Team
Last updated: November 15, 2026
Continue across the Kindr entity graph
Related evidence, peptides, and clinical tools on the same topic.
- GLP-1s in menopauseJournal
- Menopause & weight gainJournal
- SemaglutidePeptide
- TirzepatidePeptide
- GLP-1 weight care serviceMedication
This content is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.